ATE247832T1 - Reagenzien zum gebrauch als kalibratoren und kontrollen - Google Patents

Reagenzien zum gebrauch als kalibratoren und kontrollen

Info

Publication number
ATE247832T1
ATE247832T1 AT97903076T AT97903076T ATE247832T1 AT E247832 T1 ATE247832 T1 AT E247832T1 AT 97903076 T AT97903076 T AT 97903076T AT 97903076 T AT97903076 T AT 97903076T AT E247832 T1 ATE247832 T1 AT E247832T1
Authority
AT
Austria
Prior art keywords
calibrators
controls
antibodies
reagent
standards
Prior art date
Application number
AT97903076T
Other languages
English (en)
Inventor
John R Hackett Jr
Jane A Hoff
David H Ostrow
Alan M Golden
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE247832T1 publication Critical patent/ATE247832T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT97903076T 1996-01-23 1997-01-17 Reagenzien zum gebrauch als kalibratoren und kontrollen ATE247832T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/589,939 US6015662A (en) 1996-01-23 1996-01-23 Reagents for use as calibrators and controls
PCT/US1997/001074 WO1997027486A1 (en) 1996-01-23 1997-01-17 Reagents for use as calibrators and controls

Publications (1)

Publication Number Publication Date
ATE247832T1 true ATE247832T1 (de) 2003-09-15

Family

ID=24360201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903076T ATE247832T1 (de) 1996-01-23 1997-01-17 Reagenzien zum gebrauch als kalibratoren und kontrollen

Country Status (8)

Country Link
US (1) US6015662A (de)
EP (1) EP1018019B1 (de)
JP (1) JP3486418B2 (de)
AT (1) ATE247832T1 (de)
CA (1) CA2243943C (de)
DE (1) DE69724292T2 (de)
ES (1) ES2205169T3 (de)
WO (1) WO1997027486A1 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015662A (en) 1996-01-23 2000-01-18 Abbott Laboratories Reagents for use as calibrators and controls
US7790856B2 (en) * 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
WO1999033965A1 (en) 1997-12-24 1999-07-08 Diatech Pty. Ltd. Bifunctional molecules
SE9704933D0 (sv) 1997-12-30 1997-12-30 Pharmacia & Upjohn Diag Ab Metod som utnyttjar en ny kalibrator och test kit som innehåller kalibratorn
US6908770B1 (en) * 1998-07-16 2005-06-21 Board Of Regents, The University Of Texas System Fluid based analysis of multiple analytes by a sensor array
US7011940B1 (en) 1999-04-14 2006-03-14 Medical Discovery Partners Llc Quality control for cytochemical assays
US20010046496A1 (en) * 2000-04-14 2001-11-29 Brettman Lee R. Method of administering an antibody
UY26317A1 (es) * 2000-08-30 2000-10-31 Alfonso Cayota Carlos Pritsch Sistema de produccion de trombopoyetina humana por celulas de mamiferos en cultivo
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
US7700751B2 (en) * 2000-12-06 2010-04-20 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize β-amyloid peptide
MY139983A (en) * 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
US20030203412A1 (en) * 2002-04-26 2003-10-30 Aristo Vojdani Immunoassay for detection of antibodies for molds and mycotoxins
MXPA05008156A (es) * 2003-02-01 2005-09-30 Neuralab Ltd Inmunizacion activa para generar anticuerpos para beta-a soluble.
JP2008500275A (ja) * 2003-12-31 2008-01-10 セントカー・インコーポレーテツド Ｎ末端の遊離チオールを有する新規な組み換えタンパク質
US8105849B2 (en) * 2004-02-27 2012-01-31 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements
US8101431B2 (en) * 2004-02-27 2012-01-24 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
PE20061329A1 (es) * 2004-12-15 2006-12-08 Neuralab Ltd Anticuerpos ab humanizados para mejorar la cognicion
ES2396555T3 (es) * 2004-12-15 2013-02-22 Janssen Alzheimer Immunotherapy Anticuerpos que reconocen péptido beta amiloide
WO2007053186A2 (en) 2005-05-31 2007-05-10 Labnow, Inc. Methods and compositions related to determination and use of white blood cell counts
CA2613078A1 (en) * 2005-06-24 2007-01-04 Board Of Regents, The University Of Texas System Systems and methods including self-contained cartridges with detection systems and fluid delivery systems
WO2007005666A2 (en) * 2005-07-01 2007-01-11 Board Of Regents, The University Of Texas System System and method of analyte detection using differential receptors
EP1922412A4 (de) * 2005-07-15 2009-07-15 Siemens Healthcare Diagnostics Humanisierte antikörperkonjugate und entsprechende verfahren, tests, reagenzien und kits
US20070014789A1 (en) * 2005-07-15 2007-01-18 Bayer Healthcare Llc Humanized antibody conjugates and related methods, assays, reagents, and kits
US8741260B2 (en) * 2005-10-07 2014-06-03 Armagen Technologies, Inc. Fusion proteins for delivery of GDNF to the CNS
JP2009515552A (ja) * 2005-11-17 2009-04-16 ミレニアム・ファーマシューティカルズ・インコーポレイテッド α４β７インテグリン反応性ヒト化免疫グロブリン
US20070141723A1 (en) * 2005-12-16 2007-06-21 Sompuram Seshi A Immunohistochemistry staining controls
US8784810B2 (en) * 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
US8022188B2 (en) * 2006-04-24 2011-09-20 Abbott Laboratories Immunosuppressant binding antibodies and methods of obtaining and using same
JP5959795B2 (ja) 2006-08-18 2016-08-02 アーメイゲン・テクノロジーズ・インコーポレイテッドＡｒｍａｇｅｎ Ｔｅｃｈｎｏｌｏｇｉｅｓ， Ｉｎｃ． 血液脳関門送達のための物質
US7858752B2 (en) 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
WO2008131039A2 (en) * 2007-04-16 2008-10-30 Board Of Regents, The University Of Texas System Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
US8003097B2 (en) * 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
EP2146746A4 (de) * 2007-04-18 2011-03-23 Janssen Alzheimer Immunotherap Vorbeugung und behandlung von zerebraler amyloid-angiopathy
EP2997976A1 (de) 2007-07-27 2016-03-23 Armagen Technologies, Inc. Verfahren und zusammensetzungen zur erhöhung der alpha-iduronidase-aktivität im zns
SI2182983T1 (sl) * 2007-07-27 2014-09-30 Janssen Alzheimer Immunotherapy Zdravljenje amiloidogenih bolezni s humaniziranimi protitelesi proti abeta
JO3076B1 (ar) * 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
ES2539026T3 (es) * 2007-12-27 2015-06-25 Abbott Laboratories Anticuerpos anti-T. cruzi y métodos de uso
WO2009124378A1 (en) * 2008-04-07 2009-10-15 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Chimeric anti-measles antibody
US20100009389A1 (en) * 2008-07-14 2010-01-14 Masood Unnabi Khan Method of Making and Using Versatile Positive Controls and Antibody Detection Assays
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
US9533055B2 (en) 2009-03-18 2017-01-03 Armagen Technologies, Inc. Compositions and methods for blood-brain barrier delivery of IgG-decoy receptor fusion proteins
US8916154B2 (en) 2009-04-27 2014-12-23 Abbott Laboratories Antibodies against delta-5 desaturase and uses thereof
WO2011006249A1 (en) * 2009-07-13 2011-01-20 Université de Montréal Mutated sumo isoforms and uses thereof
WO2011031317A2 (en) * 2009-09-10 2011-03-17 The Board Of Regents Of The University Of Texas System Vaccine for control of trypanosoma cruzi infection and chagas disease
SI2485761T1 (sl) 2009-10-09 2019-05-31 Armagen, Inc. Postopki in sestavki za povečanje aktivnosti iduronat-2-sulfataze v CŽS
DE102009047243A1 (de) 2009-11-27 2011-06-01 Orgentec Diagnostika Gmbh Monospezifische Polypeptidreagenzien
CA2809363A1 (en) 2010-08-24 2012-03-01 Abbott Laboratories Hiv core protein specific antibodies and uses thereof
UA116189C2 (uk) 2011-05-02 2018-02-26 Мілленніум Фармасьютікалз, Інк. КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
TWI907924B (zh) 2011-05-02 2025-12-11 日商武田藥品工業股份有限公司 抗-α4β7抗體之調配物
US10379110B2 (en) * 2011-09-14 2019-08-13 Phadia Ab Calibration reagent and method
US8486399B2 (en) 2011-12-02 2013-07-16 Armagen Technologies, Inc. Methods and compositions for increasing arylsulfatase A activity in the CNS
WO2014026054A2 (en) * 2012-08-10 2014-02-13 University Of Southern California CD20 scFv-ELPs METHODS AND THERAPEUTICS
EP2893041A4 (de) * 2012-09-05 2016-07-06 Bio Rad Laboratories Chimärer anti-dsdna-/chromatin-antikörper
WO2016094627A1 (en) 2014-12-10 2016-06-16 S-Aima Holding Company, Llc Generation of hemoglobin-based oxygen carriers using elastin-like polypeptides
US10538589B2 (en) 2015-01-14 2020-01-21 Armagen Inc. Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
SE538541C2 (en) * 2015-01-19 2016-09-13 Fogelstrand Per Method for preparing a biological sample for use in an immunolabeling process
US20180003700A1 (en) 2015-01-21 2018-01-04 Kromnigon Ab Method for the formation and use of an immunolabeling complex
CN105628941B (zh) * 2015-12-22 2017-09-22 北京康彻思坦生物技术有限公司 一种IgM血清学检测质控物的制备方法
EP3427060B1 (de) * 2016-03-07 2025-08-13 Father Flanagan's Boys' Home doing Business as Boys Town National Research Hospital Nichtinvasive molekulare kontrollen
CN120795059A (zh) 2018-08-27 2025-10-17 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
CN109112113B (zh) * 2018-09-05 2023-01-10 四川安可瑞新材料技术有限公司 抗人IgG的单克隆抗体、杂交瘤细胞株、试剂盒及其应用
CN112485455B (zh) * 2020-12-09 2022-11-01 深圳市亚辉龙生物科技股份有限公司 新冠病毒抗体质控品及其制备方法
CN112881716A (zh) * 2021-01-18 2021-06-01 北京贝尔生物工程股份有限公司 一种阳性组合质控品，其制备方法及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292403A (en) * 1978-08-24 1981-09-29 Akzona Incorporated Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins
DE3112334A1 (de) * 1981-03-28 1982-10-07 Behringwerke Ag, 3550 Marburg "kuenstliche kontroll- und standardseren, verfahren zu ihrer herstellung und ihre verwendung"
US4433059A (en) * 1981-09-08 1984-02-21 Ortho Diagnostic Systems Inc. Double antibody conjugate
GB8422238D0 (en) * 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
DE3668186D1 (de) * 1985-04-01 1990-02-15 Celltech Ltd Transformierte myeloma-zell-linie und dieselbe verwendendes verfahren zur expression eines gens, das ein eukaryontisches polypeptid kodiert.
US5447837A (en) * 1987-08-05 1995-09-05 Calypte, Inc. Multi-immunoassay diagnostic system for antigens or antibodies or both
US5008183A (en) * 1988-05-10 1991-04-16 Bio-Research Laboratories, Inc. Assay system for detecting antibody and a method of producing non-human immune antibody
DE69026875T2 (de) * 1989-02-10 1996-11-14 Teijin Ltd Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
US5183735A (en) * 1989-02-27 1993-02-02 Reaads Medical Products, Inc. Method and diagnostic test kit for detection of anti-dsDNA antibodies
EP0429218A1 (de) * 1989-11-17 1991-05-29 Baxter Diagnostics Inc. Antikörper von nichtmenschlichen Primaten zum Gebrauch als positive Kontrolle für Immunglobulinbestimmungen
DK138090D0 (da) * 1990-06-06 1990-06-06 Novo Nordisk As Diagnostisk analysemetode
DE4133945A1 (de) * 1991-10-14 1993-04-15 Behringwerke Ag Kuenstliche standard- und kontrollseren, verfahren zu ihrer herstellung und ihre verwendung
US5447838A (en) * 1992-08-05 1995-09-05 Hybritech Incorporated Protein-dye conjugate for confirmation of correct dilution of calibrators
US5462852A (en) * 1992-10-28 1995-10-31 The Government Of The United States Of America, As Represented By The Secretary, Dhhs HIV Nucleocapsid protein capture assay and method of use
US5478753A (en) * 1993-06-29 1995-12-26 Pb Diagnostic Systems, Inc. Positive calibrator/control composition for an IgM serology assay and an IgM serology assay
US6015662A (en) 1996-01-23 2000-01-18 Abbott Laboratories Reagents for use as calibrators and controls

Also Published As

Publication number Publication date
CA2243943A1 (en) 1997-07-31
JP2000505543A (ja) 2000-05-09
US6015662A (en) 2000-01-18
ES2205169T3 (es) 2004-05-01
EP1018019B1 (de) 2003-08-20
DE69724292D1 (de) 2003-09-25
WO1997027486A1 (en) 1997-07-31
EP1018019A1 (de) 2000-07-12
CA2243943C (en) 2007-11-20
JP3486418B2 (ja) 2004-01-13
DE69724292T2 (de) 2004-06-17

Similar Documents

Publication Publication Date Title
DE69724292D1 (de) Reagenzien zum gebrauch als kalibratoren und kontrollen
AU2002304640A1 (en) Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
DE69624920D1 (de) Testreagentien und Testvorrichtungen
JP6713478B2 (ja) Ｐｉｖｋａ−ｉｉの測定方法、及びｐｉｖｋａ−ｉｉ免疫測定試薬又はキットの製造方法
DE602004024236D1 (en) Assay
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
DE3779704D1 (de) Verfahren und testkit zur bestimmung freier wirkstoffe in biologischen fluessigkeiten.
ATE184108T1 (de) Mca prüfung/kit zum nachweis von metallkationen
ATE51449T1 (de) Immunchemisches messverfahren fuer haptene und proteine.
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
DE50210021D1 (de) Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführte Nachweisverfahren
WO2005019831B1 (en) Methods for reducing complexity of a sample using small epitope antibodies
ATE320604T1 (de) Homogene nachweisverfahren zur bestimmung von subpopulationen eines analyten
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
ATE403866T1 (de) Verfahren zum nachweis von antikörpern in flüssigen proben
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
GR3018715T3 (en) Immunological detection method
EP1258729A3 (de) Verfahren zur Auswahl eines Antikörpers, einer Hybridomzelle, eines monoklonalen Antikörpers und seine Verwendung
DE69522021D1 (de) Monoklonaler Antikörper und seine Verwendung in einem Immunoassay
DE60037115D1 (de) Diagnostischer test für menschlisches matrix gla-protein und seine verwendung als biomarker
CA2434694A1 (en) Detection and quantification of cripto-1
DE10190630D2 (de) Verfahren zum Nachweis von Helicobacter Pylori und Heilmanii in Stuhl- und Speichelproben und Biopsiematerial
DE602005025559D1 (de) Diagnostischer Test für menschliches matrix Gla-Protein und seine Verwendung als Biomarker
ATE41242T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1018019

Country of ref document: EP

REN Ceased due to non-payment of the annual fee